Eledon Pharmaceuticals Statistics
Total Valuation
ELDN has a market cap or net worth of $67.82 million. The enterprise value is $24.69 million.
Market Cap | 67.82M |
Enterprise Value | 24.69M |
Important Dates
The last earnings date was Thursday, May 9, 2024, before market open.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ELDN has 24.20 million shares outstanding. The number of shares has increased by 109.92% in one year.
Shares Outstanding | 24.20M |
Shares Change (YoY) | +109.92% |
Shares Change (QoQ) | +21.81% |
Owned by Insiders (%) | 3.55% |
Owned by Institutions (%) | 25.99% |
Float | 18.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.90 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.30, with a Debt / Equity ratio of 0.00.
Current Ratio | 11.30 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.60% and return on invested capital (ROIC) is -56.93%.
Return on Equity (ROE) | -45.60% |
Return on Assets (ROA) | -42.80% |
Return on Capital (ROIC) | -56.93% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.99M |
Employee Count | 20 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.70% in the last 52 weeks. The beta is 0.86, so ELDN's price volatility has been lower than the market average.
Beta (1Y) | 0.86 |
52-Week Price Change | +26.70% |
50-Day Moving Average | 1.97 |
200-Day Moving Average | 1.61 |
Relative Strength Index (RSI) | 68.66 |
Average Volume (30 Days) | 161,793 |
Short Selling Information
The latest short interest is 35,362, so 0.15% of the outstanding shares have been sold short.
Short Interest | 35,362 |
Short Previous Month | 31,133 |
Short % of Shares Out | 0.15% |
Short % of Float | 0.20% |
Short Ratio (days to cover) | 0.27 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -42.76M |
Pretax Income | -39.85M |
Net Income | -39.85M |
EBITDA | -39.47M |
EBIT | -39.85M |
Earnings Per Share (EPS) | -$1.38 |
Balance Sheet
The company has $42.86 million in cash and $284,000 in debt, giving a net cash position of $42.58 million or $1.76 per share.
Cash & Cash Equivalents | 42.86M |
Total Debt | 284,000 |
Net Cash | 42.58M |
Net Cash Per Share | $1.76 |
Equity / Book Value | 74.82M |
Book Value Per Share | 3.09 |
Working Capital | 43.73M |
Cash Flow
Operating Cash Flow | -38.34M |
Capital Expenditures | n/a |
Free Cash Flow | -38.34M |
FCF Per Share | -$1.28 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ELDN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -109.92% |
Shareholder Yield | -109.92% |
Earnings Yield | -59.24% |
FCF Yield | -57.00% |
Analyst Forecast
The average price target for ELDN is $11.67, which is 316.79% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.67 |
Price Target Difference | 316.79% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -2.45% |
Stock Splits
The last stock split was on October 5, 2020. It was a reverse split with a ratio of 1:18.
Last Split Date | Oct 5, 2020 |
Split Type | Reverse |
Split Ratio | 1:18 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |